{
  "id": 17936883,
  "title": "Pharmaceuticals: Bayer raises annual targets: Group CEO sees \"turning point\"",
  "url": "https://urgent.news/2026/11/03/pharma-bayer-hebt-die-jahresziele-an-konzernchef-sieht-wendepunkt",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-03T08:40:48.000Z",
  "source": {
    "name": "Handelsblatt",
    "slug": "handelsblatt",
    "url": "https://www.handelsblatt.com/unternehmen/industrie/pharma-bayer-hebt-die-jahresziele-an-konzernchef-sieht-wendepunkt/100265241.html"
  },
  "original_language": "de",
  "account": "Bayer AG has raised its annual forecast after a strong third quarter. The company's pharmaceutical division performed better than expected, with CEO Bill Anderson saying a \"turning point\" has been reached. Bayer's adjusted operating profit (Ebitda) rose 6.9% to €1.62 billion between July and September, beating analyst predictions. The company now expects an adjusted operating profit of €9.8-10.3 billion for the year, up from its previous forecast of €9.6-10.1 billion. The Bayer stock rose over 5% to more than €52 following the announcement.",
  "summary": "The group benefits from a strong pharmaceutical business and is weathering the turbulence in the agricultural market. The group is now setting more ambitious goals, and the stock is rising sharply.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}